-

Elevance Health Names Jeff Park President of Carelon

Experienced healthcare executive will lead Carelon’s continued evolution and strategic growth

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) today announced the appointment of Jeff Park as President of Carelon, effective December 1, 2026. In this role, Park will lead Carelon through its next phase of growth, building on its momentum and expanding its ability to improve affordability, enhance the consumer experience, and create greater value for customers and the people it serves.

Park joins Carelon at a time of significant opportunity as demand continues to grow for integrated solutions that improve affordability, simplify the health care experience, and support better outcomes.

With more than two decades of experience, Park has built, transformed and scaled healthcare services, pharmacy and technology-enabled businesses. Throughout his career, he has successfully led complex integrations, managed large-scale operations and developed innovative solutions addressing complex challenges across the healthcare ecosystem. Most recently, he served as President of Waltz Health and, following Waltz Health's merger with EVERSANA, continued to lead the Waltz business while supporting enterprise growth and strategy initiatives. Previously, Park held senior leadership roles at OptumRx, Catamaran, WellDyneRx and Diplomat Pharmacy.

“Carelon is central to our strategy and an important driver of growth for Elevance Health,” said Gail K. Boudreaux, President and Chief Executive Officer, Elevance Health. “Jeff brings deep healthcare experience and a proven track record of growing businesses, driving execution, and creating value for customers. As we build on Carelon's momentum, his leadership will help accelerate growth, expand our impact, and further our work to make health care more affordable, simpler, and more personalized.”

Carelon brings together its capabilities and trusted partnerships to develop solutions around each person's needs. This connected approach strengthens care coordination and helps consumers and care providers navigate the health care system more effectively.

Under Park’s leadership, Carelon will focus on strengthening operational performance, scaling its solutions and lowering the total cost of care. This work will deepen Carelon’s contribution to Elevance Health and position the business to capture emerging opportunities across the health care ecosystem.

About Elevance Health

Elevance Health is a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company supports consumers, families, and communities across the entire healthcare journey – connecting them to the care, support, and resources they need to lead better lives. Elevance Health’s companies serve approximately 103 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, home health, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on X and Elevance Health on LinkedIn.

Contacts

Media Contact:
Leslie Porras
Leslie.Porras@ElevanceHealth.com

Investor Relations:
Investor.Relations@elevancehealth.com

Elevance Health, Inc.

NYSE:ELV

Release Versions

Contacts

Media Contact:
Leslie Porras
Leslie.Porras@ElevanceHealth.com

Investor Relations:
Investor.Relations@elevancehealth.com

More News From Elevance Health, Inc.

Elevance Health Reports Third Quarter 2026 Results; Raises Full-Year Guidance

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported third quarter 2026 results ahead of expectations. "Elevance Health's third quarter results reflect stronger execution across our diversified portfolio and underscore the earnings power of the business. We are raising our 2026 earnings outlook and remain confident in delivering at least 12% growth in adjusted diluted earnings per share in 2027 from our higher earnings baseline of at least $26.753. By bringing together the...

Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2026 Results on October 21, 2026

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release third quarter 2026 financial results on October 21, 2026 at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (International) 800-3...

Elevance Health’s Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today that its affiliated health plans will offer 2027 Medicare Advantage plans designed to help members navigate healthcare more confidently through meaningful choice, simpler benefit experiences and personalized support that reflects individual health needs. As members evaluate Medicare coverage for 2027, many want to understand their benefits, connect to care, manage healthcare costs and know where to turn for support throu...
Back to Newsroom